Monday - Friday:
9:00am - 5:00pm (EST)
This year's theme is, "Linking Innovative Programs, Treatment and Research to Improve Care". Read more to register.
The White House Petition to bring national attention to the Sickle Cell Treatment Act – H.R. Bill 5124 is up and it’s time for us all to roll up our sleeves and get to work in obtaining signatures. SCDAA and the SCD Community is requesting that the President of the United States acknowledge and declare of...
SCDAA along with its members, advocates and champions has secured a big win for the sickle cell community. On Wednesday, July 16, 2014 Representatives Danny K. Davis (D-IL) and Michael C. Burgess (R-TX) revealed bipartisan legislation...
Baxter International Inc. announced the acquisition of AesRx, LLC, including the development and commercialization of Aes-103, an investigational prophylactic treatment for sickle cell disease (SCD).
SCDAA would like to thank you for being an advocate for sickle cell disease!
Continue to check our website for updates.